Concord Biotech IPO opens today: GMP, review, other details. Apply or not?
Concord Biotech IPO: The initial public offering (IPO) of Concord Biotech Limited has opened today for subscribers and it will remain open for bidders till 8th August 2023. The public issue aims to raise ₹1,551 crore and the book build issue is completely offer for sale (OFS) in nature. The bio-pharma company has fixed Concord Biotech IPO price band at ₹705 to ₹741 per equity share.
According to market observers, Concord Biotech share price has started to trade in unlisted market. They said that shares of Concord Biotech area available at a premium of ₹150 per equity share in grey market today. 1] Concord Biotech IPO GMP today: According to market observers, Concord Biotech IPO grey market premium (GMP) today is ₹150.
2] Concord Biotech IPO price band: The bio-pharma company has fixed price band of the public issue at ₹705 to ₹741 per equity share. 3] Concord Biotech IPO date: The public issue has opened for subscription today and it will remain open for subscribers till 8th August 2023. 4] Concord Biotech IPO lot size: A bidder will be able to apply in lots and one lot will comprise 20 company shares.
5] Concord Biotech IPO size: The bio-pharma company aims to raise ₹1,551 crore from its initial offer. 6] Concord Biotech IPO allotment date: The tentative date for share allocation is 11th August 2023. 7] Concord Biotech IPO registrar: Link Intime India Private Ltd has been appointed as official registrar of the public issue.
8] Concord Biotech IPO listing: The public issue has been proposed to list on BSE and NSE. 9] Concord Biotech IPO listing date: The public issue is most likely to list on 18th August 2023. On Concord Biotech IPO review, Choice Broking report says, "At the higher price band, CBL is demanding a P/E
. Read more on livemint.com
